Additionally, beta-blockers have been shown to modulate angiogenic peptides such as vascular endothelial growth factor, hypoxia-inducible factor 1-alpha, and fibroblast growth factor, which are crucial in hemangioma development [22,24]. The gene discussed is HIF1A; the disease is hemangioma.